Effects of Switching From Olanzapine, Quetiapine, and Risperidone to Aripiprazole on 10-Year Coronary Heart Disease Risk and Metabolic Syndrome Status: Results From a Randomized Controlled Trial
Schizophrenia Research - Netherlands
doi 10.1016/j.schres.2013.01.013
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2013
Authors
Publisher
Elsevier BV